# Atara Biotherapeutics, Inc.: Form 8-K, filed Jun 12, 2026

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2026-06-12
- Accepted by EDGAR: Jun 12, 2026, 16:05 ET
- Period: 2026-06-09
- Accession: 0001213900-26-068264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000121390026068264/ea0294561-8k_atara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000121390026068264/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000121390026068264/ea0294561-8k_atara.htm

Filed Jun 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-068264. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.